| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Harmony Biosciences Holdings, Inc.'s insiders have reduced their positions by a net 72,406 shares worth roughly $3.1M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 24.5K | $907.8K | - | |
| Other | 13.1K | $485.5K | - | |
| CEO | 7.3K | $271.9K | - | |
| Other | 4.3K | $160.2K | - | |
| Other | 1.5K | $54.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2022 | Jeffrey Dierks62 | Chief Commercial Officer | Sale+OE | 28,971 | $47.00 | $1,361,727.44 | - | +22.2% | -30.4% | |
| Aug 15, 2022 | John C Jacobs53 | President, CEO | Sale+OE | 40,000 | $51.07 | $2,042,812.84 | - | +15.1% | -35.4% | |
| Aug 10, 2022 | Andreas Wicki71 | Director | Sell | 578,552 | $53.77 | $31,106,469.22 | -16.1% | +11.8% | -38.9% | |
| Aug 8, 2022 | Jack Nielsen76 | Director | Sell | 250,000 | $52.73 | $13,183,300.00 | -7.6% | +5.8% | -38.3% | |
| Aug 5, 2022 | Andreas Wicki71 | Director | Sell | 72,586 | $52.73 | $3,827,163.14 | -2.0% | +14.2% | -36.0% | |
| Aug 2, 2022 | Jack Nielsen76 | Director | Sell | 75,117 | $55.22 | $4,147,960.74 | -2.2% | -6.2% | -41.2% | |
| Jul 18, 2022 | Jack Nielsen76 | Director | Sell | 40,087 | $55.19 | $2,212,401.53 | -1.2% | -5.8% | -30.6% | |
| Jul 13, 2022 | Jack Nielsen76 | Director | Sell | 5,773 | $55.04 | $317,745.92 | -0.2% | -11.6% | -35.8% | |
| Jul 11, 2022 | Jack Nielsen76 | Director | Sell | 10,768 | $55.05 | $592,810.28 | -0.3% | -13.5% | -37.4% | |
| Jul 7, 2022 | Jack Nielsen76 | Director | Sell | 300,741 | $55.39 | $16,657,443.02 | -8.1% | -12.6% | -39.7% |